Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05125822 · ClinicalTrials.gov registry record · NA

Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity

A NA study of Childhood Obesity, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Recruiting
Registry status
NA
Development phase
260
Enrollment target
1
Study location

NCT05125822: Recruiting NA study of Childhood Obesity, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

NCT05125822 is a NA study of Childhood Obesity that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 260 participants, below the 555-participant average among 43 other Childhood Obesity trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05125822, a NA study of Childhood Obesity, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

RECRUITING
Registry status
NA
Development phase
260 participants
Enrollment target
1
Study location

Study Summary

In this study, doctors want to find out more about why people who lose weight often regain the weight that they have lost once they resume a regular diet and whether hormones might play a role in weight regain. The study is divided into two parts, called the meal replacement period and the follow-up period. The meal replacement period will consist of drinking a shake for breakfast and lunch and eating a frozen meal for dinner that is calorie controlled. Individuals will also be asked to eat two servings of fruit and three servings of vegetables each day. The study will provide the shakes and the frozen entrees, participants are asked to supply the fruits and vegetables. Participation in this study will last for up to 35 weeks. There will be 10 in-person visits and 13 visits by phone or over Zoom over the 35 weeks.

Primary Outcome

We hypothesize that the greater the initial weight loss with MRT the greater the fat mass regain at 26 weeks.

Conditions Studied

Interventions

  • OTHER Meal replacement and lifestyle modification

Study Locations (1)

Illinois

  • Ann & Robert H Lurie Children's Hospital of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2023-08-26
Est. Completion 2028-01-01
Phase NA

What NCT05125822 shows while recruiting

NCT05125822 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 555-participant average among 43 other Childhood Obesity trials with a reported enrollment target (53% lower).

The record links to 1 condition, with Childhood Obesity appearing as the primary indexed condition, and to 1 intervention - of which Meal replacement and lifestyle modification is the first listed.

NCT05125822 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05125822 about?

NCT05125822 is a clinical study titled "Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity". In this study, doctors want to find out more about why people who lose weight often regain the weight that they have lost once they resume a regular diet and whether hormones might play a role in weight regain. The study is divided into two parts, called the meal replacement period and the follow-up...

What is the current status of trial NCT05125822?

This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2023-08-26. Estimated completion is 2028-01-01.

What conditions does trial NCT05125822 study?

This clinical trial studies the following conditions: Childhood Obesity.

What interventions are being tested in trial NCT05125822?

The interventions under investigation include: Meal replacement and lifestyle modification (OTHER).

Who is sponsoring clinical trial NCT05125822?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05125822 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05125822's enrollment target sits among peer trials

260 19th of 43 higher than 25 of 43 other Childhood Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02283996 · 260 participants · Phase 4

    Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

  • NCT03276793 · 260 participants · NA

    Brain Connectivity in Depression

  • NCT03407469 · 260 participants

    Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

  • NCT03713125 · 260 participants · NA

    Executive Function in Early Childhood

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05125822, the US trial registry maintained by the National Library of Medicine. NCT05125822 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.